The nation's top vaccine advisory panel is expected to debate on Thursday whether to delay the first dose of the hepatitis B ...
A group of advisers to the Centers for Disease Control and Prevention is preparing to vote on whether the agency should scrap ...
As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...
As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...
The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...
GlobalData expects the chronic hepatitis B therapeutics market across major markets to climb from $1.5 billion in 2024 to ...
Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the ...
Richard Angell, CEO of the Terrence Higgins Trust, considers the success of opt-out HIV testing in A&E – and what it could ...
Two years after di breast surgery, di cancer still spread enter her bone, lungs and liver. "Once cancer don comot from wia e ...
December 2, 2025 - By Jackie Fortiér - Working out of a tribal-owned hospital in Anchorage, Alaska, liver specialist Brian ...
Explore the enduring challenges of treating HIV, its unique properties, and the progress made since the virus's discovery.